{
  "id": 15953140,
  "title": "Ianalumab's Road to Approval for Sjogren's Looks Bumpier",
  "url": "https://urgent.news/2026/10/21/ianalumabs-road-to-approval-for-sjogrens-looks-bumpier",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-21T21:00:00.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/rheumatology/generalrheumatology/123512"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- Findings from a pair of randomized trials in Sjögren's disease with the anti-B cell biologic ianalumab have now been published and it's no longer clear that they're sufficient to support regulatory approvals. The two trials...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}